Clinical trial
Oxaliplatin in Cancer Patients With Impaired Kidney Function
NCT00001835 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001835 |
|---|---|
| Title | Oxaliplatin in Cancer Patients With Impaired Kidney Function |
| Official title | A Phase I Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Disease, Neoplasm, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | Oxaliplatin |
| Enrollment | 60 |
| Start date | Sep 1, 1999 |
| Completion | Dec 1, 2001 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: